MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$172,042K
Net Income
-$258,131K
Net Profit Margin
-150.04%
EPS
-$3.48
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2024-12-31
Product revenue, net
172,042
Other revenue
19,547
Total revenue
191,589
Cost of product revenue
12,550
Research and development
200,518
Selling, general and administrative
256,652
Total operating expenses
469,720
Loss from operations
-278,131
Interest and other income, net
26,000
Total interest and other income
26,000
Equity method investment loss
-6,000
Net loss
-258,131
Basic EPS
-3.48
Diluted EPS
-3.48
Basic Average Shares
74,132,811
Diluted Average Shares
74,132,811
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest and other
income, net
$26,000K
Net loss
-$258,131K
Total interest and
other income
$26,000K
Product revenue, net
$172,042K
Other revenue
$19,547K
Loss from operations
-$278,131K
Total revenue
$191,589K
Equity method
investment loss
-$6,000K
Total operating
expenses
$469,720K
Selling, general and
administrative
$256,652K
Research and development
$200,518K
Cost of product
revenue
$12,550K
Buy us a coffee
SpringWorks Therapeutics, Inc. (SWTX)
SpringWorks Therapeutics, Inc. (SWTX)